U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hemophilia B leyden

MedGen UID:
1845499
•Concept ID:
C5848256
•
Disease or Syndrome
Synonym: Hemophilia B Leyden
SNOMED CT: Factor 9 deficiency Leyden type (1336117005); Factor IX deficiency Leyden type (1336117005); Hemophilia B Leyden (1336117005)
 
Monarch Initiative: MONDO:0850054
OMIM®: 300746
Orphanet: ORPHA617930

Professional guidelines

PubMed

Genotype-phenotype analyses of Iranian patients with hemophilia B (Leyden -) and hemophilia B (Leyden +): A single-center study.
Moghadam AA, Manafzadeh AR, Dajliry K, Ramezan F, Nikoonia MR, Abdolkarimi B, Hamidpour M, Tabibian S
Transfus Apher Sci 2024 Aug;63(4):103962. Epub 2024 Jun 20 doi: 10.1016/j.transci.2024.103962. PMID: 38964254
Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
Vidaud D, Tartary M, Costa JM, Bahnak BR, Gispert-Sanchez S, Fressinaud E, Gazengel C, Meyer D, Goossens M, Lavergne JM
Hum Genet 1993 Apr;91(3):241-4. doi: 10.1007/BF00218264. PMID: 8478007

Recent clinical studies

Etiology

First case report of hemophilia B Leyden in Japan.
Yamashita A, Nagae C, Mori M, Ashikaga T, Kojima T, Taki M
Int J Hematol 2017 Jul;106(1):135-137. Epub 2017 Feb 7 doi: 10.1007/s12185-017-2194-4. PMID: 28168417
Hemophilia B: molecular pathogenesis and mutation analysis.
Goodeve AC
J Thromb Haemost 2015 Jul;13(7):1184-95. Epub 2015 May 18 doi: 10.1111/jth.12958. PMID: 25851415Free PMC Article
An experimental verification of the predicted effects of promoter TATA-box polymorphisms associated with human diseases on interactions between the TATA boxes and TATA-binding protein.
Savinkova L, Drachkova I, Arshinova T, Ponomarenko P, Ponomarenko M, Kolchanov N
PLoS One 2013;8(2):e54626. Epub 2013 Feb 12 doi: 10.1371/journal.pone.0054626. PMID: 23424617Free PMC Article
Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays.
Poort SR, van der Linden IK, Krommenhoek-van Es C, Briët E, Bertina RM
Thromb Haemost 1986 Feb 28;55(1):122-8. PMID: 3704999
Hemophilia B Leyden: a sex-linked hereditary disorder that improves after puberty.
Briët E, Bertina RM, van Tilburg NH, Veltkamp JJ
N Engl J Med 1982 Apr 1;306(13):788-90. doi: 10.1056/NEJM198204013061306. PMID: 7062952

Diagnosis

The Molecular Basis of FIX Deficiency in Hemophilia B.
Shen G, Gao M, Cao Q, Li W
Int J Mol Sci 2022 Mar 2;23(5) doi: 10.3390/ijms23052762. PMID: 35269902Free PMC Article
First case report of hemophilia B Leyden in Japan.
Yamashita A, Nagae C, Mori M, Ashikaga T, Kojima T, Taki M
Int J Hematol 2017 Jul;106(1):135-137. Epub 2017 Feb 7 doi: 10.1007/s12185-017-2194-4. PMID: 28168417
Hemophilia B: molecular pathogenesis and mutation analysis.
Goodeve AC
J Thromb Haemost 2015 Jul;13(7):1184-95. Epub 2015 May 18 doi: 10.1111/jth.12958. PMID: 25851415Free PMC Article

Therapy

Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays.
Poort SR, van der Linden IK, Krommenhoek-van Es C, Briët E, Bertina RM
Thromb Haemost 1986 Feb 28;55(1):122-8. PMID: 3704999
The prophylactic treatment of hemophilia B Leyden with anabolic steroids.
Briët E, Wijnands MC, Veltkamp JJ
Ann Intern Med 1985 Aug;103(2):225-6. doi: 10.7326/0003-4819-103-2-225. PMID: 4014904

Prognosis

First case report of hemophilia B Leyden in Japan.
Yamashita A, Nagae C, Mori M, Ashikaga T, Kojima T, Taki M
Int J Hematol 2017 Jul;106(1):135-137. Epub 2017 Feb 7 doi: 10.1007/s12185-017-2194-4. PMID: 28168417
Hemophilia B: molecular pathogenesis and mutation analysis.
Goodeve AC
J Thromb Haemost 2015 Jul;13(7):1184-95. Epub 2015 May 18 doi: 10.1111/jth.12958. PMID: 25851415Free PMC Article
An experimental verification of the predicted effects of promoter TATA-box polymorphisms associated with human diseases on interactions between the TATA boxes and TATA-binding protein.
Savinkova L, Drachkova I, Arshinova T, Ponomarenko P, Ponomarenko M, Kolchanov N
PLoS One 2013;8(2):e54626. Epub 2013 Feb 12 doi: 10.1371/journal.pone.0054626. PMID: 23424617Free PMC Article
Moderate hemophilia B Leyden: identification by polymerase chain reaction, sequencing, and oligomer restriction.
Coyle TE, Spicer T, Michalovic D, Poiesz BJ
Am J Hematol 1994 Jul;46(3):234-40. doi: 10.1002/ajh.2830460314. PMID: 7677806
Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
Vidaud D, Tartary M, Costa JM, Bahnak BR, Gispert-Sanchez S, Fressinaud E, Gazengel C, Meyer D, Goossens M, Lavergne JM
Hum Genet 1993 Apr;91(3):241-4. doi: 10.1007/BF00218264. PMID: 8478007

Clinical prediction guides

Hemophilia B: molecular pathogenesis and mutation analysis.
Goodeve AC
J Thromb Haemost 2015 Jul;13(7):1184-95. Epub 2015 May 18 doi: 10.1111/jth.12958. PMID: 25851415Free PMC Article
An experimental verification of the predicted effects of promoter TATA-box polymorphisms associated with human diseases on interactions between the TATA boxes and TATA-binding protein.
Savinkova L, Drachkova I, Arshinova T, Ponomarenko P, Ponomarenko M, Kolchanov N
PLoS One 2013;8(2):e54626. Epub 2013 Feb 12 doi: 10.1371/journal.pone.0054626. PMID: 23424617Free PMC Article
An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B Leyden.
Kurachi S, Huo JS, Ameri A, Zhang K, Yoshizawa AC, Kurachi K
Proc Natl Acad Sci U S A 2009 May 12;106(19):7921-6. Epub 2009 Apr 28 doi: 10.1073/pnas.0902191106. PMID: 19416882Free PMC Article
Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivation.
Boccia LM, Lillicrap D, Newcombe K, Mueller CR
Mol Cell Biol 1996 May;16(5):1929-35. doi: 10.1128/MCB.16.5.1929. PMID: 8628259Free PMC Article
Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
Vidaud D, Tartary M, Costa JM, Bahnak BR, Gispert-Sanchez S, Fressinaud E, Gazengel C, Meyer D, Goossens M, Lavergne JM
Hum Genet 1993 Apr;91(3):241-4. doi: 10.1007/BF00218264. PMID: 8478007

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Reviews

    Related information

    • GTR
      Related information in GTR
    • GTR(Clinical)
      Clinical tests in GTR
    • MeSH
      Related Medical Subject Headings
    • OMIM
      Related records in OMIM
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...